Peer review reports
From: A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol
Original Submission |
28 Oct 2014 |
Submitted |
Original manuscript
|
8 Dec 2014 |
Author responded |
Author comments - Corran Roberts
|
Resubmission - Version 2 |
8 Dec 2014 |
Submitted |
Manuscript version 2
|
Publishing |
11 Dec 2014 |
Editorially accepted |
|
19 Dec 2014 |
Article published |
10.1186/1471-2407-14-983
|
Learn about peer review